Literature DB >> 32076670

Donor and Recipient Characteristics in Heart Transplantation Are Associated with Altered Myocardial Tissue Structure and Cardiac Function.

Ryan S Dolan1, Amir A Rahsepar1, Julie Blaisdell1, Roberto Sarnari1, Kambiz Ghafourian1, Jane E Wilcox1, Sadiya S Khan1, Esther E Vorovich1, Jonathan D Rich1, Clyde W Yancy1, Allen S Anderson1, James C Carr1, Michael Markl1.   

Abstract

PURPOSE: To use structure-function cardiac MRI in the evaluation of relationships between donor and heart transplantation (HTx) recipient characteristics and changes in cardiac tissue structure and function. HTx candidates and donor hearts are evaluated for donor-recipient matches to improve survival, but the impact of donor and recipient characteristics on changes in myocardial tissue and function in the transplanted heart is not fully understood.
MATERIALS AND METHODS: Cardiac MRI at 1.5 T was performed from August 2014 to June 2017 in 58 HTx recipients (mean age, 51.1 years ± 12.6 [standard deviation], 26 female patients) and included T2 mapping (to evaluate edematous and/or inflammatory changes), precontrast and postcontrast T1 mapping (allowing the calculation of extracellular volume fraction [ECV] to estimate interstitial expansion), and tissue phase mapping (allowing the calculation of myocardial velocities and twist). Donor and recipient demographics (age, sex, height, weight, and body mass index [BMI]) and comorbidities (hypertension, diabetes, and smoking history) were evaluated for relationships with cardiac MRI measures.
RESULTS: Sex-influenced cardiac MRI measures of myocardial tissue and function are as follows: Female HTx recipients demonstrated increased precontrast T1 (P = .002) and reduced systolic peak long-axis velocities (P = .015). Increased age of the donor heart was associated with elevated T2 (r = 0.32; P < .05) and ECV (r = 0.47; P < .01), indicating increased edema and interstitial expansion, as well as impaired diastolic peak long-axis velocities (r = 0.41; P < .01). Recipient-donor differences in age, weight, and BMI were significantly associated with elevated ECV (r = 0.36-0.48; P < .05). Hypertension in donors resulted in increased ECV (31.0% ± 4.2 vs 26.0% ± 3.3; P = .001).
CONCLUSION: Donor and HTx recipient characteristics were significantly associated with cardiac MRI-derived measures of myocardial tissue structure and function.© RSNA, 2019. 2019 by the Radiological Society of North America, Inc.

Entities:  

Year:  2019        PMID: 32076670      PMCID: PMC6939741          DOI: 10.1148/ryct.2019190009

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  36 in total

1.  Fast phase contrast cardiac magnetic resonance imaging: improved assessment and analysis of left ventricular wall motion.

Authors:  Michael Markl; Britta Schneider; Jürgen Hennig
Journal:  J Magn Reson Imaging       Date:  2002-06       Impact factor: 4.813

2.  Magnetic resonance tissue phase mapping of myocardial motion: new insight in age and gender.

Authors:  Daniela Föll; Bernd Jung; Elfriede Schilli; Felix Staehle; Annette Geibel; Jürgen Hennig; Christoph Bode; Michael Markl
Journal:  Circ Cardiovasc Imaging       Date:  2009-12-08       Impact factor: 7.792

3.  Impact of donor age on survival after heart transplantation: an analysis of the United Network for Organ Sharing (UNOS) registry.

Authors:  Daniel J Weber; I-Wen Wang; Adam S A Gracon; Yaron M Hellman; David A Hormuth; Thomas C Wozniak; Z A Hashmi
Journal:  J Card Surg       Date:  2014-07-19       Impact factor: 1.620

4.  Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.

Authors:  Christian Erbel; Nodira Mukhammadaminova; Christian A Gleissner; Nael F Osman; Nina P Hofmann; Christian Steuer; Mohammadreza Akhavanpoor; Susanne Wangler; Sultan Celik; Andreas O Doesch; Andreas Voss; Sebastian J Buss; Philipp A Schnabel; Hugo A Katus; Grigorios Korosoglou
Journal:  JACC Cardiovasc Imaging       Date:  2016-03

5.  Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry.

Authors:  Kiran K Khush; Jessica T Kubo; Manisha Desai
Journal:  J Heart Lung Transplant       Date:  2012-03-13       Impact factor: 10.247

6.  Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation.

Authors:  Ryan S Dolan; Amir A Rahsepar; Julie Blaisdell; Kenichiro Suwa; Kambiz Ghafourian; Jane E Wilcox; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Allen S Anderson; Clyde W Yancy; Jeremy D Collins; James C Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2019-03-13

7.  The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.

Authors:  Eric S Weiss; Jeremiah G Allen; Nishant D Patel; Stuart D Russell; William A Baumgartner; Ashish S Shah; John V Conte
Journal:  Circ Heart Fail       Date:  2009-07-08       Impact factor: 8.790

Review 8.  Advanced therapies for end-stage heart failure.

Authors:  Jason N Katz; Sarah B Waters; Ian B Hollis; Patricia P Chang
Journal:  Curr Cardiol Rev       Date:  2015

9.  Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method.

Authors:  Peter Kellman; Joel R Wilson; Hui Xue; Martin Ugander; Andrew E Arai
Journal:  J Cardiovasc Magn Reson       Date:  2012-09-10       Impact factor: 5.364

10.  Myocardial tissue remodeling in adolescent obesity.

Authors:  Ravi V Shah; Siddique A Abbasi; Tomas G Neilan; Edward Hulten; Otavio Coelho-Filho; Alison Hoppin; Lynne Levitsky; Sarah de Ferranti; Erinn T Rhodes; Avram Traum; Elizabeth Goodman; Henry Feng; Bobak Heydari; William S Harris; Daniel M Hoefner; Joseph P McConnell; Ravi Seethamraju; Carsten Rickers; Raymond Y Kwong; Michael Jerosch-Herold
Journal:  J Am Heart Assoc       Date:  2013-08-20       Impact factor: 5.501

View more
  1 in total

1.  Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy.

Authors:  Nazia Husain; Kae Watanabe; Haben Berhane; Aditi Gupta; Michael Markl; Cynthia K Rigsby; Joshua D Robinson
Journal:  J Cardiovasc Magn Reson       Date:  2021-11-22       Impact factor: 5.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.